DigiPath Labs Validates New Extraction Technology

LAS VEGAS, NV--(Marketwired - Oct 20, 2016) - DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), an independent cannabis testing lab and media firm, recently completed a successful validation of Fluid Management Systems' (FMS) pressure liquid extractor (PLEâ) for use across four different cannabis matrices.

The extraction methods currently used in the cannabis testing industry for both cannabinoids and pesticides is labor and reagent intensive, and highly unreproducible. In contrast, FMS's PLEâ instrument uses high pressure which can complete the extraction of cannabinoids, terpenes and pesticides in less than five minutes, with consistency, efficiency and reproducible results from sample to sample.

Cindy Orser, PhD, Chief Science Officer at Digipath Labs, commented, "One of the biggest expenses in cannabis sample processing is related to the amount of time required to homogenize, weigh, and extract each sample for the myriad of analytical tests. My interest in investigating FMS's PLEâ was to reduce both time and reagent cost and at the same time increase consistency and reproducibility."

Extraction technology developed for the food industry for high lipid and fat content products has not been previously applied to cannabis, and that is where FMS's expertise and instrumentation comes into focus.

Tom Hall, VP of Marketing & Sales at FMS, located in Watertown, MA, stated, "As the innovator in extraction instrumentation for the food and environmental industry, it made sense for FMS to look for thought leaders in the cannabis testing space to evaluate our technology for use in the cannabis industry." 

"Following the application and validation of extraction protocols using the FMS PLE instrument for cannabis flower, edibles, extracts and lotions, DigiPath labs plans to begin using the FMS instrument immediately", said Dr. Orser.

About DigiPath, Inc.
DigiPath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry's best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. DigiPath's two business units are DigiPath Labs and TNM News Corp. DigiPath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis.

For more information please visit http://www.digipath.com/.

Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, governmental regulation of the cannabis industry, the demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.